NCT00733057View on ClinicalTrials.gov

Minocycline for the Treatment of Early-Phase Schizophrenia

PHASE3CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

August 31, 2003

Primary Completion Date

March 31, 2007

Study Completion Date

March 31, 2007

Conditions
Negative and Cognitive Symptoms in Schizophrenia
Interventions
DRUG

Minocycline

Minocycline as an add-on drug (200 mg/day)

DRUG

Placebo (200 mg/day)

Trial Locations (1)

70300

The Emotion-Cognition Research Center, The Shalvata Mental Health Care Center, P.O.B. 94., Hod HaSharon

All Listed Sponsors
collaborator

Abarbanel Mental Health Center

OTHER_GOV

lead

Shalvata Mental Health Center

OTHER

NCT00733057 - Minocycline for the Treatment of Early-Phase Schizophrenia | Biotech Hunter | Biotech Hunter